Glutathione synthesis by red blood cells in type 2 diabetes mellitus

Redox Report

Volumn 13, Issue 6, 2008, Pages 277-282

  Whillier, Stephney ^a   Raftos, Julia Elizabeth ^a   Kuchel, Philip William ^b  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Advanced glycation end products; Antioxidant; Erythrocytes; Free radicals; Glutathione; Reactive oxygen species; Type 2 diabetes mellitus

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; 5,5' DITHIOBIS(2 NITROBENZOIC ACID); ANTIDIABETIC AGENT; GLUTATHIONE; INSULIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CELL ACTIVITY; CELL FUNCTION; CELLULAR STRESS RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME METABOLISM; ENZYME SUBSTRATE; ENZYME SYNTHESIS; ERYTHROCYTE METABOLISM; FEMALE; HUMAN; HUMAN CELL; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RECYCLING; STEADY STATE;

ADULT; AGE FACTORS; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; ERYTHROCYTES; FEMALE; GLUTATHIONE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REACTIVE OXYGEN SPECIES;

EID: 58049220316     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100008X309046     Document Type: Article

References (47)

1. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arterioscler Thromb Vasc Biol 2004; 24: 816-823.
2. Dumaswala UJ, Zhuo L, Jacobsen DW et al. Protein and lipid oxidation of banked human erythrocytes: Role of glutathione. Free Radic Biol Med 1999; 27: 1041-1049.
3. Keenoy BM, Vertommen J, de Leeuw I. Divergent effects of different oxidants on glutathione homeostasis and protein damage in erythrocytes from diabetic patients: Effects of high glucose. Mol Cell Biochem 2001; 225: 59-73.
4. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846.
5. Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
6. Robertson RP, Harmon J, Tran PO et al. Glucose toxicity in β-cells: Type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 2003; 52: 581-587.
7. Thornalley P. Modification of the glyoxalase system in human red blood cells by glucose in vitro. J Biochem 1988; 254: 751-755.
8. Arese P, Schwarzer E. Metabolic Disorders: Red Cell Alterations in Diabetes Mellitus. Berlin: Springer, 2003.
9. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-319.
10. Baynes J. Perspectives in diabetes: Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
11. Hsieh CL, Yen GC, Chen HY. Antioxidant activities of phenolic acids on ultraviolet radiation-induced erythrocyte and low density lipoprotein oxidation. J Agric Food Chem 2005; 53: 6151-6156.
12. Rice-Evans C, Baysal E. Iron-mediated oxidative stress in erythrocytes. Biochem J 1987; 244: 191-196.
13. Iles KE, Liu RM. Mechanisms of glutamate cysteine ligase (GCL) induction by 4-hydroxynonenal. Free Radic Biol Med 2005; 38: 547-556.
14. Thornalley P, McLellan A, Lo T et al. Negative association between erythrocyte reduced glutathione concentration and diabetic complications. Clin Sci 1996; 91: 575-582.
15. Beard K, Shangari N, Wu B et al. Metabolism, not auto-oxidation, plays a role in alpha-oxoaldehyde and reducing sugar-induced erythrocyte GSH depletion: Relevance for diabetes mellitus. Mol Cell Biochem 2003; 252: 331-338.
16. Aoshiba K, Nakajima Y, Yasui S et al. Red blood cells inhibit apoptosis of human neutrophils. Blood 1999; 93: 4006-4010.
17. Sailaja YR, Baskar R, Saralakumari D. The antioxidant status during maturation of reticulocytes to erythrocytes in type 2 diabetes. Free Radic Biol Med 2003; 35: 133-139.
18. Giustarini D, Milzani A, Dalle-Donne I et al. Red blood cells as a physiological source of glutathione for extracellular fluids. Blood Cells Mol Dis 2008; 40: 174-179.
19. Lang CA, Mills BJ, Mastropaolo W et al. Blood glutathione decreases in chronic diseases. J Lab Clin Med 2000; 135: 402-405.
20. Raftos J, Whillier S, Chapman B et al. Kinetics of uptake and deacetylation of N-acetylcysteine by human erythrocytes. Int J Biochem Cell Biol 2007; 39: 1698-1706.
21. Richman P, Meister A. Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione. J Biol Chem 1975; 250: 1422-1426.
22. Murakami K, Takahito K, Ohtsuka Y et al. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 1989; 38: 753-758.
23. Dincer Y, Akcay T, Alademir Z et al. Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. Metabolism 2002; 51: 1360-1362.
24. Yoshida K, Hirokawa J, Tagami S et al. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 1995; 38: 201-210.
25. Vijayalingam S, Parthiban A, Shanmugasundaram K et al. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabet Med 1996; 13: 715-719.
26. Martin-Gallan P, Carrascosa A, Gussinye M et al. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003; 34: 1563-1574.
27. Bono A, Caimi G, Catania A et al. Red cell peroxide metabolism in diabetes mellitus. Horm Metab Res 1986; 19: 264-266.
28. Matsubara L, Ferreira A, Mornero M et al. Influence of diabetes mellitus on the glutathione redox system of human red blood cells. Braz J Med Biol Res 1992; 25: 331-335.
29. Straface E, Rivabene R, Masella R et al. Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes: Protective effects of N-acetylcysteine. Biochem Biophys Res Commun 2002; 290: 1393-1398.
30. Atalay M, Laaksonen D, Niskanen L et al. Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress. Acta Physiol Scand 1997; 161: 195-201.
31. Di Simplicio P, De Giorgio LA, Cardaioli E et al. Glutathione, glutathione utilizing enzymes and thioltransferase in platelets of insulin-dependent diabetic patients: Relation with platelet aggregation and with microangiopathic complications. Eur J Clin Invest 1995; 25: 665-669.
32. Richie JJ, Skowronski L, Abraham P et al. Blood glutathione concentrations in a large-scale human study. Clin Chem 1996; 42: 71-75.
33. Gil J, Siems W, Mazurek B et al. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res 2006; 40: 495-505.
34. Constantin A, Constantinescu E, Dumitrescu M et al. Effects of ageing on carbonyl stress and antioxidant defense in RBCs of obese type 2 diabetic patients. J Cell Mol Med 2005; 9: 683-691.
35. Griffith OW, Mulcahy RT. The enzymes of glutathione synthesis: gamma-glutamylcysteine synthetase. Adv Enzymol Relat Areas Mol Biol 1999; 73: 60-80.
36. Beisswenger PJ, Howell S, Smith K et al. Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim Biophys Acta 2003; 1637: 98-106.
37. Raftos J, Dwarte T, Luty A et al. Direct measurement of the rate of glutathione synthesis in 1-chloro-2,4-dinitrobenzene treated human erythrocytes. Redox Report 2006; 11: 9-14.
38. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidised glutathione applications to mammalian blood and other tissues. Anal Biochem 1969; 27: 502-522
39. Owens C, Belcher R. A colorimetric micro-method for the determination of glutathione. J Biol Chem 1965; 94: 705-711.
40. Memisogullari R, Taysi S, Bakan E et al. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 2003; 21: 291-296.
41. Richie JJ, Abraham P, Leutzinger Y. Long-term stability of blood glutathione and cysteine in humans. Clin Chem 1996; 42: 1100-1105.
42. Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 1999; 27: 922-935.
43. Srivastava S, Beutler E. The transport of oxidised glutathione from human erythrocytes. J Biol Chem 1969; 244: 9-16.
44. Yang Y, Dieter MZ, Chen Y et al. Initial characterization of the glutamatecysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J Biol Chem 2002; 277: 49446-49452.
45. Chen Y, Shertzer HG, Schneider SN et al. Glutamate cysteine ligase catalysis: Dependence on ATP and modifier subunit for regulation of tissue glutathione levels. J Biol Chem 2005; 280: 33766-33774.
46. Moellering D, McAndrew J, Patel RP et al. The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells: A role for gammaglutamylcysteine synthetase and gamma-glutamyl transpeptidase. FEBS Lett 1999; 448: 292-296.
47. Seghrouchni I, Drai J, Bannier E et al. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta 2002; 321: 89-96.